Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted Interest Coverage Ratio of 5.97 for Q2 2026, up 186.84% on a QoQ basis from 2.08 in Q1 2026, and down 11.17% year-over-year from 6.72 in Q2 2025.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals has reported Interest Coverage Ratio for 14 years, with the latest figure at 5.97 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio fell 11.17% year-over-year to 5.97 in Q2 2026; TTM through Jun 2026 was 4.37, a 38.14% decrease from a year earlier, with the FY2025 full-year figure at 5.51, down 18.61% from the prior year.
- Interest Coverage Ratio was 5.97 for Q2 2026 at Amphastar Pharmaceuticals, up from 2.08 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 84.0 in Q1 2023, with the low at 2.08 in Q1 2026.
- Average Interest Coverage Ratio over 5 years is 22.17, with a median of 6.56 recorded in 2024.
- The largest YoY upside for Interest Coverage Ratio was 60.57% in 2024 against a maximum downside of 93.36% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 71.65 in 2022, then plunged by 92.03% to 5.71 in 2023, then gained by 23.08% to 7.03 in 2024, then dropped by 23.57% to 5.37 in 2025, then rose by 11.09% to 5.97 in 2026.
- The last three Interest Coverage Ratio figures came in at 5.97 (Q2 2026), 2.08 (Q1 2026), and 5.37 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 579.00 |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.97 |
| Mar 31, 2026 | 2.08 |
| Dec 31, 2025 | 5.37 |
| Sep 30, 2025 | 4.03 |
| Jun 30, 2025 | 6.72 |
| Mar 31, 2025 | 5.93 |
| Dec 31, 2024 | 7.03 |
| Sep 30, 2024 | 8.52 |
| Jun 30, 2024 | 6.41 |
| Mar 31, 2024 | 5.58 |
| Dec 31, 2023 | 5.71 |
| Sep 30, 2023 | 5.30 |
| Jun 30, 2023 | 10.24 |
| Mar 31, 2023 | 84.00 |
| Dec 31, 2022 | 71.65 |
| Sep 30, 2022 | 41.04 |
| Jun 30, 2022 | 62.53 |
| Mar 31, 2022 | 60.88 |
| Dec 31, 2021 | 144.36 |
| Sep 30, 2021 | 47.00 |